Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders: A 14-Year Real-Life Experience
Discussion
Over 14 years of long-term RTX treatment, IgG levels gradually decreased, and the frequency of hypo-IgG increased to 41% of the patients. Patients with prolonged memory B-cell depletion after RTX, previous mitoxantrone history, hypo-IgG at baseline, or obesity were at risk of developing RTX-induced hypogammaglobulinemia. Nevertheless, infection rates remained low during treatment, and reduced immunoglobulin levels were not associated with an increased incidence of infections.
Source: Neurology Neuroimmunology and Neuroinflammation - Category: Neurology Authors: Kim, S.-H., Park, N. Y., Kim, K. H., Hyun, J.-W., Kim, H. J. Tags: All Demyelinating disease (CNS), Devic's syndrome Research Article Source Type: research
More News: Brain | Disability | Eating Disorders & Weight Management | Neurology | Obesity | Rituxan